Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Clinical trial NCT06009627 · COMPLETED
Trial details
- NCT number
- NCT06009627
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2025-03-11
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.